Similar to SUM159 breast cancer cells, we discovered that treatment of LPS blocker (PMB) reduced the LPS‐mediated expression of S100A7 in S100A7‐overexpressing MDA‐MB‐231 cells (Fig. 6C). This evidence concerns the gene S100A7 and breast carcinoma.